About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
SMART QUOTES
Smart
Quotes
Sequent Scientific Ltd.
Industry :
Pharmaceuticals & Drugs
BSE Code
512529
ISIN Demat
INE807F01027
Book Value
41.91
NSE Code
SEQUENT
Dividend Yield %
0.00
Market Cap
44384.39
P/E
302.55
EPS
0.59
Face Value
2
BSE
NSE
04-Sep-2025
BSE
NSE
NSE F & O
04-Sep-2025
BSE
NSE
NSE F & O
Last Price
177.30
Net Change
0.85
% Change
0.48%
Prev.Close
176.45
Open
176.55
High
177.70
Low
174.90
Volume
45553
Last Price
177.12
Net Change
0.71
% Change
0.4%
Prev.Close
176.41
Open
177.90
High
178.29
Low
175.26
Volume
259434
Value
8055413
Best Buy
0.00
Best Sell
0.00
Best Quantity
0
Sell Quantity
0
Today's Range
177.70
52-Week High
240.90
52-Week Low
111.00
Value
45955273.98
Best Buy
177.12
Best Sell
0.00
Best Quantity
183
Sell Quantity
0
Today's Range
178.29
52-Week High
240.70
52-Week Low
117.35
Open Price
High Price
Low Price
Last Price
Prev Close
Change
% Change
Average Price
Underlying Value
Number of contracts traded
Turnover in Rs. Lakhs
Open Interest
Change in O I
% Change in O I
%
Today
|
1W
|
1M
|
1Y
You need to upgrade your Flash Player
Best Bid
Best Offer
Quantity
0
Price
0.00
Quantity
0
Price
0.00
Best Bid
Best Offer
Quantity
183
Price
177.12
Quantity
0
Price
0.00
Best Bid
Best Offer
Quantity
Price
Quantity
Price
Holding Details
More
Latest Corporate Events
Book Closure
23-Aug-19
29-Aug-19
Dividend
25 %
10-Sep-21
Company News
11-08-2025
Sequent Scientific inform...
16-07-2025
Sequent Scientific inform...
14-07-2025
Sequent Scientific inform...
29-05-2025
SeQuent secures approvals...
21-05-2025
Sequent Scientific inform...
20-02-2025
Sequent Scientific inform...
11-02-2025
Sequent Scientific report...
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.